IMC-Chicago, LLC
- SEC CIK
- 0001452861
- Latest filing
- Aug 6, 2026
SRPT holding history
Sarepta Therapeutics, Inc. in every 13F filed by IMC-Chicago, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings
- Shares (Q2 2026)
- 11,546
- Value
- $207.5K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 11,546 | $207.5K | <0.1% | −2,349−16.9% | Reduced | Holders |
| Q1 2026 | 13,895 | $302.4K | <0.1% | −29,397−67.9% | Reduced | Holders |
| Q4 2025 | 43,292 | $931.6K | <0.1% | +17,214+66.0% | Added | Holders |
| Q3 2025 | 26,078 | $502.5K | <0.1% | +26,078 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −17,985−100.0% | Sold out | Holders |
| Q1 2025 | 17,985 | $1.15M | <0.1% | +17,985 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −15,193−100.0% | Sold out | Holders |
| Q4 2021 | 15,193 | $1.37M | 0.1% | +268+1.8% | Added | Holders |
| Q3 2021 | 14,925 | $1.38M | 0.1% | +2,580+20.9% | Added | Holders |
| Q2 2021 | 12,345 | $960.0K | 0.1% | +577+4.9% | Added | Holders |
| Q1 2021 | 11,768 | $877.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.